Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Robertson · SciRah

Researcher profile · Semantic Scholar

D. Robertson

Share profile

D. Robertson — researcher profile on SciRah

h-index: 12
Works: 30
Citations: 702

Most-cited papers

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
P. Ambery, V. Parker, M. Stumvoll, M. Posch +9 more
2018The Lancet252 citations
Semantic Scholar
Efficacy, safety, and mechanistic insights of cotadutide a dual receptor glucagon-like peptide-1 and glucagon agonist.
V. Parker, D. Robertson, Tao Wang, D. Hornigold +10 more
2019Journal of Clinical Endocrinology and Metabolism107 citations Open access
Semantic Scholar
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Non-cirrhotic MASH with Fibrosis.
Sudha S. Shankar, Samuel Daniels, D. Robertson, Janeli Sarv +5 more
2024Clinical Gastroenterology and Hepatology48 citations Open access
Semantic Scholar
CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6+ cells in an experimental suction blister
G. Bouma, S. Zamuner, Kirsty Hicks, A. Want +9 more
2017British Journal of Clinical Pharmacology48 citations Open access
Semantic Scholar
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
V. Parker, D. Robertson, E. Erazo-Tapia, B. Havekes +16 more
2023Nature Metabolism46 citations Open access
Semantic Scholar
Increased levels of 3-hydroxykynurenine parallel disease severity in human acute pancreatitis
C. Skouras, Xiaozhong Zheng, M. Binnie, N. Homer +18 more
2016Scientific Reports34 citations Open access
Semantic Scholar
70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis
M. E. Barton, T. Otiker, Lakshmi Vasist Johnson, D. Robertson +7 more
201434 citations
Semantic Scholar
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon‐like peptide‐1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes
Michiko Asano, Akiko Sekikawa, Hyosung Kim, R. Gasser +4 more
2021Diabetes, obesity and metabolism33 citations
Semantic Scholar
Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study.
D. Raccah, T. Haak, D. Huet, L. Monnier +4 more
2012Diabetes & Metabolism26 citations
Semantic Scholar
Dual glucagon‐like peptide‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity
R. Golubic, J. Kennet, V. Parker, D. Robertson +11 more
2024Diabetes, obesity and metabolism18 citations Open access
Semantic Scholar
Algorithm for the introduction of rapid‐acting insulin analogues in patients with type 2 diabetes on basal insulin therapy
Owens, C. Van Schalkwyk, P. Smith, S. Beer +6 more
200913 citations Open access
Semantic Scholar
Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84
Jolanta U. Weaver, D. Robertson, S. Atkin
2004Diabetes, obesity and metabolism13 citations Open access
Semantic Scholar
Safety/tolerability, efficacy and pharmacokinetics of 600‐μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m2 or higher: A phase I, randomized, double‐blind, placebo‐controlled study
Michiko Asano, Akiko Sekikawa, M. Sugeno, O. Matsuoka +2 more
2023Diabetes, obesity and metabolism12 citations Open access
Semantic Scholar
354-OR: Cotadutide (medi0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Modulates Hepatic Glycogen and Fat Content
D. Robertson, L. Hansen, P. Ambery, Russell L. Esterline +7 more
20205 citations
Semantic Scholar
MEDI0382, a GLP/Glucagon Receptor Dual Agonist, Significantly Reduces Hepatic Fat Content in Subjects with Type 2 Diabetes Mellitus
Meenakshi Jain, L. Tsai, D. Robertson, B. Hirshberg +3 more
2018Diabetes5 citations
Semantic Scholar
988-P: MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, Promotes a Dose-Dependent Increase in Gastric Emptying Time
D. Robertson, V. Parker, P. Ambery, M. Petrone +6 more
2019Diabetes3 citations
Semantic Scholar
1705-P: Obesity Phenotype Exhibit Differential Signatures of Circulating Biomarkers with Susceptible Obesity-Related Comorbidities
W. Qi, Xiaomei Tu, D. Robertson, Andres Acosta +1 more
2024Diabetes1 citations
Semantic Scholar
#3000 EFFICACY AND SAFETY OF COTADUTIDE, A DUAL GLP1-GLUCAGON RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND T2DM
V. Selvarajah, D. Robertson, Lars H Hansen, L. Jermutus +6 more
2023Nephrology, Dialysis and Transplantation1 citations Open access
Semantic Scholar
Author response for "Pharmacokinetics, safety, tolerability, and efficacy of cotadutide, a GLP ‐1 and glucagon receptor dual agonist, in phase 1/2 trials in overweight or obese participants of Asian descent with or without T2D"
Michiko Asano, Akiko Sekikawa, Hyosung Kim, R. Gasser +4 more
20211 citations Open access
Semantic Scholar
105-OR: An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Cotadutide on Energy Balance in Overweight and Obese Subjects with Type 2 Diabetes Mellitus
R. Golubic, J. Kennet, V. Parker, D. Robertson +6 more
2021Diabetes1 citations
Semantic Scholar
1017-P: Continuous Glucose Monitoring Reveals Comprehensive Glucose Control with MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity
V. Parker, D. Robertson, Tao Wang, D. Hornigold +8 more
2019Diabetes1 citations
Semantic Scholar
Tu1472 Multimodal Assessment of Gastric Residence Time, Whole Bowel Transit, Esophageal Function and Gastro-Esophageal Reflux Following Administration of the Motilin Agonist (GSK962040) in Healthy Subjects
A. Hobson, O. Dewit, M. O'Donnell, K. Hacquoil +3 more
20121 citations Open access
Semantic Scholar
Changes in hepatic fat fraction as assessed by MRI-PDFF are correlated with changes in markers of hepatic inflammation, disease activity and fibrosis in biopsy-proven non-cirrhotic NASH with fibrosis
S. Daniels, D. Robertson, José L. García Sánchez, Janeli Sarv +5 more
2022Journal of Hepatology0 citations
Semantic Scholar
659-P: Cotadutide (MEDI0382) Is Well Tolerated at Doses Up to 600 µG with Blood Glucose-Lowering Activity in Japanese Patients with T2DM
Miichiko Asano, Akiko Sekikawa, M. Sugeno, Hitoshi Shimada +2 more
2021Diabetes0 citations
Semantic Scholar
951-P: Cotadutide (MEDI0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Is Well Tolerated (<600 µG) with Robust Effects on Blood Glucose in Patients with T2DM
D. Robertson, L. Hansen, Meenakshi Jain, V. Parker +4 more
20200 citations
Semantic Scholar
989-P: MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity: Safety Study in Subjects of Japanese and Chinese Descent
D. Robertson, M. Petrone, L. Tsai, R. Gasser
2019Diabetes0 citations
Semantic Scholar
1010-P: Effects of MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, on Amino Acids, Ketones, and Free Fatty Acids
V. Parker, D. Robertson, Tao Wang, D. Hornigold +8 more
2019Diabetes0 citations
Semantic Scholar
Effects of MEDI0382 on Pancreatic and Incretin Hormones
V. Parker, L. Tsai, D. Robertson, M. Petrone +4 more
2018Diabetes0 citations
Semantic Scholar
Robust Glucose Control and Weight Loss after Six Weeks of Treatment with MEDI0382, a Balanced GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes
P. Ambery, M. Stumvoll, M. Posch, T. Heise +8 more
2018Diabetes0 citations
Semantic Scholar
MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes—A Multiple-Ascending-Dose Study
D. Robertson, M. Stumvoll, M. Posch, T. Heise +9 more
2018Diabetes0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Parker×15
Invite
V. Parker — researcher profile on SciRah
L. Jermutus×15
Invite
L. Jermutus — researcher profile on SciRah
P. Ambery×13
Invite
P. Ambery — researcher profile on SciRah
M. Petrone×11
Invite
M. Petrone — researcher profile on SciRah

×9

Invite

B. Hirshberg — researcher profile on SciRah

Invite

T. Heise — researcher profile on SciRah

L. Plum-Moerschel×7

Invite

L. Plum-Moerschel — researcher profile on SciRah

Invite

M. Posch — researcher profile on SciRah

Invite

L. Tsai — researcher profile on SciRah

Invite

Tao Wang — researcher profile on SciRah

C. Rondinone×4

Invite

C. Rondinone — researcher profile on SciRah

Invite

J. Meier — researcher profile on SciRah